SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA's earnings release is the primary catalyst, with the market anticipating significant movement based on the report's implications for the AI sector. Community discussions revolve around potential partnerships, Saudi Arabian investments, and whether the stock is overvalued or poised for further gains. Some traders express concern about a potential "sell the news" event, while others anticipate a substantial rally if NVIDIA delivers strong results.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors weigh the impact of recent earnings, a partnership with OpenAI, and broader consumer spending trends. The community is discussing whether Target can regain its footing amidst increased competition and shifting consumer preferences, with some citing concerns over store experience and brand perception, while others express optimism about its long-term potential and dividend payouts. News of layoffs and cost-cutting measures are also being considered as potential catalysts for change.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as the community discusses potential catalysts related to deep-sea mining and critical mineral supply chains. Some traders are pointing to technical indicators suggesting a possible breakout, while others cite potential government interest and partnerships in the sector as reasons for optimism. Community members are actively debating the company's prospects and potential impact from upcoming news.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to an initial immune-complete response in a metastatic triple-negative breast cancer (TNBC) patient treated with its drug, paxalisib, in combination with pembrolizumab and chemotherapy.  The community is actively discussing the potential of this breakthrough, especially given the rarity of complete responses in metastatic TNBC, while some are concerned about potential dilution or whether the news is already priced in.  Broader discussions involve the drug's potential in glioblastoma and immuno-oncology, and the company's efforts to regain NASDAQ compliance.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending due to a recently awarded $44M DARPA contract to advance its Very Low Earth Orbit mission using its SabreSat platform, sparking optimism about the company's growth potential. The community is actively discussing the significance of this contract and its potential impact on Redwire's position in the space industry, with some members predicting substantial future gains. Despite some bearish sentiment and concerns about dilution, the DARPA contract win is seen as a positive catalyst for the stock.

SEMrush Holdings, Inc. engages in the provision of an online visibility management software-as-a-service platform. The company was founded by Oleg Shchegolev and Dmitry Melnikov in 2008 and is headquartered in Boston, MA.

SEMrush Holdings Inc - Ordinary Shares - Class A

SEMrush is trending amid reports of a potential acquisition by Adobe, driving significant pre-market activity and options trading. While some community members express excitement about the company's AI and enterprise initiatives, others are discussing concerns about data collection and Google updates impacting the industry. Overall, the stock's volatility and potential for a deal are key points of discussion.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT) is trending with community members highlighting its potential as a "sleeper" crypto and its integration with a fitness app that rewards users for physical activity. Some users are optimistic about the long-term prospects and potential for gains through staking, while others are anticipating increased adoption and utility as the project develops. Discussions also include potential token burns and the upcoming U.S. launch of the Sweat Wallet.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending due to mixed Phase 3 trial results for its sickle cell disease drug, mitapivat, with community sentiment focused on missed endpoints and management's execution. While some see potential in the hemoglobin response and safety profile, others express disappointment and question the company's leadership. Upcoming FDA catalysts and existing cash reserves are also being weighed against concerns about value creation and executive competence.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is trending due to its strong community and potential within the Injective ecosystem, particularly as Injective's EVM mainnet launch approaches. Community members highlight $NONJA's strong performance against $INJ, its high burned liquidity, and the unique NFT collections. The community sees $NONJA as a leveraged play on $INJ, anticipating significant gains as the Injective ecosystem develops.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

SGML is trending due to a mix of factors, including lithium price fluctuations and speculation around potential short squeezes. Community discussions revolve around the stock's high short interest and potential for increased lithium prices to drive the stock higher. Some traders are betting on a short squeeze, while others point to the company's financials and production updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Campbell & CO Investment Adviser LLC Buys Shares of 83,245 Zevra Therapeutics, Inc. $ZVRA

Campbell & CO Investment Adviser LLC purchased a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Los Angeles Capital Management LLC Buys Shares of 121,225 Zevra Therapeutics, Inc. $ZVRA

Los Angeles Capital Management LLC purchased a new stake in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F...

Research Analysts Set Expectations for ZVRA FY2025 Earnings

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Investment analysts at William Blair lifted their FY2025 earnings estimates for Zevra Therapeutics in a research report issued to clients and...

FY2025 EPS Estimate for Zevra Therapeutics Raised by Analyst

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for Zevra Therapeutics in a note issued to...

William Blair Analysts Boost Earnings Estimates for ZVRA

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - William Blair lifted their Q3 2026 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a report issued on Wednesday, November...

FY2026 EPS Estimates for ZVRA Decreased by Cantor Fitzgerald

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2026 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on...

Zevra Therapeutics (NASDAQ:ZVRA) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded Zevra Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Zevra Therapeutics (NASDAQ:ZVRA) Given New $24.00 Price Target at Cantor Fitzgerald

Cantor Fitzgerald decreased their price target on shares of Zevra Therapeutics from $29.00 to $24.00 and set an "overweight" rating for the company in a research note on Thursday...

Zevra Therapeutics (NASDAQ:ZVRA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Zevra Therapeutics (NASDAQ:ZVRA - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate...

Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of +75.00% and -1.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.05	--	--	N/A
Q3 '25	-$0.03	-$0.01	70.37%	BEAT
Q2 '25	$2.26	$1.21	-46.55%	MISSED
Q1 '25	-$0.18	-$0.06	66.93%	BEAT
Q4 '24	-$0.40	-$0.67	-69.62%	MISSED

ZVRA
Zevra Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest ZVRA News

ZVRAZevra Therapeutics Inc